The inquiry represents a seek for native medical practitioners providing a particular onabotulinumtoxinA remedy protocol. This protocol is indicated for the prophylactic remedy of continual migraine in adults. The consumer is searching for a handy location to entry this therapeutic intervention.
Accessing this remedy can considerably cut back the frequency and severity of migraine complications, bettering high quality of life. The FDA permitted onabotulinumtoxinA for continual migraine in 2010, establishing it as a acknowledged and accepted remedy for people who expertise 15 or extra headache days per thirty days, every lasting 4 hours or extra.